425: Redwoods Acquisition Corp. Secures Non-Redemption Agreement to Bolster ANEW Medical Merger

Redwoods Acquisition Corp. (RWOD) has entered into a non-redemption agreement with certain investors to rescind previous redemption requests, supporting the proposed business combination with ANEW Medical, Inc.

Summary

• Redwoods Acquisition Corp. (RWOD) announced on May 9, 2024, that it entered into a non-redemption agreement with Backstop Investors.
• These investors agreed to reverse their prior election to redeem up to 360,000 shares of RWOD common stock.
• The redemption requests were initially made in connection with the special meeting held on April 12, 2024, to approve the business combination with ANEW Medical, Inc.
• RWOD will pay the Backstop Investors cash from its trust account, calculated as the number of Backstop Shares multiplied by the Redemption Price (approximately $11.20 per share as of May 8, 2024), less $5.00 per share.
• As of May 8, 2024, RWOD had received requests to redeem a total of 1,589,776 RWOD Shares.
• Following these redemptions, RWOD will have approximately 170,418 RWOD Shares outstanding.
• Stockholders who wish to withdraw their previously submitted redemption requests may do so by requesting RWOD's transfer agent, Continental Stock Transfer & Trust Company, to return such shares.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. Securing the non-redemption agreement is a positive step towards completing the merger, but the cost of the agreement and the remaining risks temper the overall outlook.

Positives

• The non-redemption agreement reduces the number of shares being redeemed, increasing the cash available for the business combination with ANEW Medical, Inc.
• The agreement provides more certainty regarding the closing of the business combination.
• Existing stockholders have the option to withdraw their previously submitted redemption requests.

Negatives

• RWOD will need to use cash from its trust account to compensate the Backstop Investors, reducing the amount of capital available for ANEW Medical post-merger.
• The Backstop Investors receive a premium for reversing their redemption requests, effectively being paid $6.20 per share ($11.20 $5.00) while other shareholders only receive $11.20 per share if they redeem.

Risks

• The business combination is still subject to customary closing conditions, including approval from Redwoods stockholders.
• The actual Redemption Price may vary slightly due to applicable taxes.
• The success of ANEW Medical's business and strategies is subject to various risks and uncertainties.
• The ability to recognize the anticipated benefits of the business combination is not guaranteed.

Future Outlook

The document contains forward-looking statements regarding the proposed transaction, anticipated benefits, integration plans, expected synergies, revenue opportunities, future financial and operating performance, and the expected timing of the transactions. These statements are subject to risks and uncertainties.

Industry Context

Special Purpose Acquisition Companies (SPACs) often use non-redemption agreements to ensure sufficient capital remains in the trust account to complete a merger. High redemption rates have been a challenge for many SPAC deals, making these agreements increasingly common.

Comparison to Industry Standards

• Other SPACs, such as Digital World Acquisition Corp. (DWAC) and Churchill Capital Corp IV (CCIV), have also used non-redemption agreements to mitigate high redemption rates.
• The $5.00 discount to the redemption price offered to Backstop Investors is within the typical range observed in similar non-redemption agreements.
• The success of the ANEW Medical merger will depend on factors such as market conditions, regulatory approvals, and the company's ability to execute its business plan, similar to other companies in the biotechnology sector.

Stakeholder Impact

• Shareholders who did not redeem their shares may benefit from the business combination if ANEW Medical performs well.
• Employees of ANEW Medical may experience changes as a result of the merger.
• The business combination could impact customers and suppliers of ANEW Medical depending on the integration strategy.

Next Steps

• Redwoods must obtain approval from its stockholders for the business combination.
• The parties must satisfy all other closing conditions outlined in the business combination agreement.
• RWOD will pay the Non-Redemption Cash to Backstop Investor following the consummation of the Business Combination.

Key Dates

Keywords

Redwoods Acquisition Corp, ANEW Medical, Non-Redemption Agreement, Business Combination, Merger, SPAC, Redemption, Backstop Investors, RWOD